Vanguard Group Inc. trimmed its position in Crocs, Inc. (NASDAQ:CROX – Free Report) by 3.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,924,880 shares of the textile maker’s stock after selling 154,352 shares during the period. Vanguard Group Inc. owned approximately 9.49% of Crocs worth $411,474,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Boston Partners grew its holdings in Crocs by 2,659.1% during the second quarter. Boston Partners now owns 1,688,383 shares of the textile maker’s stock valued at $171,003,000 after purchasing an additional 1,627,190 shares during the period. Alliancebernstein L.P. boosted its position in shares of Crocs by 5.8% during the second quarter. Alliancebernstein L.P. now owns 1,180,405 shares of the textile maker’s stock worth $119,551,000 after purchasing an additional 64,672 shares in the last quarter. LSV Asset Management grew its holdings in shares of Crocs by 3.2% in the 3rd quarter. LSV Asset Management now owns 1,107,500 shares of the textile maker’s stock valued at $92,532,000 after buying an additional 34,380 shares during the period. Thrivent Financial for Lutherans grew its holdings in shares of Crocs by 4.2% in the 2nd quarter. Thrivent Financial for Lutherans now owns 768,304 shares of the textile maker’s stock valued at $77,814,000 after buying an additional 31,083 shares during the period. Finally, Patient Capital Management LLC increased its position in shares of Crocs by 17.0% in the 3rd quarter. Patient Capital Management LLC now owns 588,794 shares of the textile maker’s stock valued at $49,194,000 after buying an additional 85,416 shares in the last quarter. Institutional investors own 93.44% of the company’s stock.
Analyst Upgrades and Downgrades
CROX has been the topic of several recent analyst reports. KeyCorp reiterated a “sector weight” rating on shares of Crocs in a report on Thursday, January 22nd. Weiss Ratings lowered Crocs from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday. Needham & Company LLC lifted their price objective on Crocs from $100.00 to $118.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Wall Street Zen cut Crocs from a “buy” rating to a “hold” rating in a research note on Sunday, November 9th. Finally, Piper Sandler restated a “neutral” rating and set a $95.00 target price on shares of Crocs in a report on Thursday, February 12th. Four analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $103.42.
Crocs Stock Down 1.4%
NASDAQ:CROX opened at $92.70 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.74 and a current ratio of 1.27. The company has a market cap of $4.66 billion, a PE ratio of -73.57, a PEG ratio of 1.09 and a beta of 1.56. Crocs, Inc. has a 52-week low of $73.21 and a 52-week high of $122.84. The stock has a 50-day simple moving average of $88.25 and a 200 day simple moving average of $84.77.
Crocs (NASDAQ:CROX – Get Free Report) last released its earnings results on Thursday, February 12th. The textile maker reported $2.29 EPS for the quarter, beating the consensus estimate of $1.92 by $0.37. The firm had revenue of $957.64 million for the quarter, compared to analysts’ expectations of $916.16 million. Crocs had a positive return on equity of 45.17% and a negative net margin of 2.01%.The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.52 EPS. Crocs has set its FY 2026 guidance at 12.880-13.350 EPS and its Q1 2026 guidance at 2.670-2.770 EPS. On average, sell-side analysts expect that Crocs, Inc. will post 13.2 EPS for the current fiscal year.
Insider Buying and Selling
In related news, EVP Anne Mehlman sold 12,145 shares of the firm’s stock in a transaction on Friday, February 20th. The shares were sold at an average price of $100.06, for a total value of $1,215,228.70. Following the completion of the transaction, the executive vice president owned 131,112 shares of the company’s stock, valued at approximately $13,119,066.72. This trade represents a 8.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.00% of the company’s stock.
About Crocs
Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.
Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.
Recommended Stories
- Five stocks we like better than Crocs
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROX – Free Report).
Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.
